Independent Director · OptimizeRx Corp (OPRX)

Chair, Nominating/Governance Committee

Catherine Klema director compensation at OptimizeRx (FY2025): $228K

Fiscal year 2025 director compensation for Catherine Klema at OptimizeRx Corp. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 30, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Catherine Klema’s full pay file as a PDF — free

More than this page: up to 10 years of Catherine’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Catherine Klema and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

OptimizeRx Director Compensation Table · all 3 fiscal years held
In US dollars, as OptimizeRx reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$78,000$149,994——$227,994
FY2024$56,500$149,999$0$0$206,499
FY2023$0$0$0$0—

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: OptimizeRx Corp DEF 14A filed April 30, 2026, accession 0001213900-26-049698, and prior-year filings. Open the filing on EDGAR.

How this page was built: the OptimizeRx Corp filed document, accession 0001213900-26-049698. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.

Get the OptimizeRx Board Governance Report

$227,994 Catherine Klema, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 30, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

OptimizeRx pays directors a $40,000 cash retainer and $150,000 in RSUs.

Committees

FY2025 · as the proxy prints them

Audit · Nominating/Governance (Chair) · Strategic

The rest of the OptimizeRx board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Gregory WassonIndependent Director$200,994
James LangIndependent Director$203,994
Lynn O'Connor VosIndependent Director$268,994
Mariyamma Varghese PrestiIndependent Director—
Patrick SpanglerIndependent Director$234,994
Stephen SilvestroDirector—

The full OptimizeRx compensation record

free company brief

This page is one director within OptimizeRx's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the OptimizeRx proxy · each links to its own free brief

Order OPRX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report